Repligen

RGEN

RGEN
Repligen Stock Quote
$100.71 $0.81 0.8%
BATS BZX Real Time Price as of January 17, 2020, 8:00 p.m. EST View Interactive RGEN Charts

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

News & Analysis: Repligen

The Fool has written over 100 articles on Repligen.

All

Market Moves

Earnings





Interactive Chart